Though the FDA has requested no new data, the additional information reflects a major amendment to Rhythm’s supplemental new drug application (sNDA), allowing the FDA more time to go over the ...

Agentic AI was a point of emphasis on the first day of the 2025 Veeva Commercial summit held in Madrid, Spain.

Tariffs increase operational costs by raising prices for raw materials, APIs, and finished drugs, complicating logistics and ...

Clever Culture is bringing automation to pharma microbiology, with its AI tech now used by global heavyweights such as ...

Market opportunities lie in modernizing software development and validation approaches, emphasizing agility and continuous validation to meet changing needs, while ensuring compliance with FDA ...

Long before he found himself in the middle of a multibillion-dollar takeover battle for a coveted new weight-loss drug, Whit ...

October 2025 saw a wave of M&As and biotech deals in various therapeutic fields, particularly for therapies addressing ...

Eli Lilly and Novo Nordisk have agreed pricing deals for GLP-1RA brands, a pivotal moment in the obesity treatment market.

Donald Trump has signed deals with the pharma giants Novo Nordisk and Eli Lilly to lower the prices of antiobesity drugs and get more US citizens taking them. The deal will cover tirzepatide (Lilly’s ...

Track earnings movers from Sun Pharma to Paytm as Indian markets close lower; see which stocks to watch today!

Ibnsina Pharma ranked first in non-pharma product distribution across pharmacies in Egypt during the first nine months of ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...